Sign in
4

Changes in Ownership

Elevance Health, Inc. Filed Acc 0001127602-18-016509

EVP & CEO, IngenioRx sold 59,421 shares at an average $224.41 ($13,334,390)

  • EVP & CEO, IngenioRx acquired 59,421 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN BRIAN T · EVP & CEO, IngenioRx

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-03 Exercise or conversion : show line 1 in the form +9,756 $61.88 $603,701 25,619 D
2018-05-03 Exercise or conversion : show line 2 in the form +7,489 $146.93 $1,100,359 33,108 D
2018-05-03 Exercise or conversion : show line 3 in the form +14,830 $89.44 $1,326,395 47,938 D
2018-05-03 Exercise or conversion : show line 4 in the form +4,478 $152.78 $684,149 52,416 D
2018-05-03 Exercise or conversion : show line 5 in the form +16,232 $131.80 $2,139,378 68,648 D
2018-05-03 Exercise or conversion : show line 6 in the form +6,636 $166.97 $1,108,013 75,284 D
2018-05-03 Sale : show line 7 in the form −54,497 $224.32 $12,224,767 20,787 D
2018-05-03 Sale : show line 8 in the form −4,924 $225.35 $1,109,623 15,863 D
Open-market sales · 59,421 sh · avg $224.41 · $13,334,390

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2018-05-03 Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) −9,756 0 D
2018-05-03 Exercise or conversion : show line 10 in the form Employee Stock Option (Right to Buy) −7,489 0 D
2018-05-03 Exercise or conversion : show line 11 in the form Employee Stock Option (Right to Buy) −14,830 0 D
2018-05-03 Exercise or conversion : show line 12 in the form Employee Stock Option (Right to Buy) −4,478 896 D
2018-05-03 Exercise or conversion : show line 13 in the form Employee Stock Option (Right to Buy) −16,232 8,116 D
2018-05-03 Exercise or conversion : show line 14 in the form Employee Stock Option (Right to Buy) −6,636 13,272 D
Loading xslF345X03/form4.xml…